Skip to main content

Analysts Offer Insights on Healthcare Companies: Xenon (XENE) and BioLife Solutions (BLFS)

Tipranks - Tipranks - Sun Dec 28, 2025

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Xenon (XENE – Research Report) and BioLife Solutions (BLFS – Research Report) with bullish sentiments.

Claim 70% Off TipRanks This Holiday Season

BioLife Solutions (BLFS)

Maxim Group analyst Jason McCarthy maintained a Buy rating on BioLife Solutions yesterday and set a price target of $34.00. The company’s shares closed last Friday at $24.90.

According to TipRanks.com, McCarthy has 0 stars on 0-5 stars ranking scale with an average return of -14.0% and a 33.4% success rate. McCarthy covers the Healthcare sector, focusing on stocks such as Genenta Science SpA Sponsored ADR, Reviva Pharmaceuticals Holdings, and CERo Therapeutics Holdings. ;'>

BioLife Solutions has an analyst consensus of Strong Buy, with a price target consensus of $32.29.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).